Kaneka Eurogentec is a leading supplier to the pharmaceutical industry, offering comprehensive contract manufacturing and development services. The company operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), specialising in the production of small molecules, biologics, and cell and gene therapy products. With a strong focus on custom drug substance manufacturing, Kaneka Eurogentec provides solutions for oligonucleotides, peptides, mRNA, plasmid DNA, and recombinant proteins intended for human clinical and commercial use. The expertise of the company is further complemented by its capabilities in research and development, regulatory services, and a commitment to high-quality standards, evidenced by its FDA-inspected facilities.

Services include:
- Small Molecule
- Biologics
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Research & Development
- Regulatory Services
- APIs (Active Pharmaceutical Ingredients)
- Protein and Peptide
- Analytical Services

Kaneka Eurogentec is dedicated to delivering innovative solutions that meet the evolving needs of the pharmaceutical industry. For more information, please visit eurogentec.com.